Halozyme Therapeutics Inc. logo

Halozyme Therapeutics Inc. (HALO)

Market Closed
5 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
63. 33
+0.38
+0.6%
$
8.54B Market Cap
20.87 P/E Ratio
0% Div Yield
1,550,641 Volume
2.74 Eps
$ 62.95
Previous Close
Day Range
62.6 63.98
Year Range
46.26 79.5
Want to track HALO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 73 days
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
17 Feb 2026 (In 2 months)
1.92
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
3 Nov 2025
1.63
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
29 Oct 2025
1.43
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
28 Oct 2025
1.61
Cons. EPS
1.72
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
12 Aug 2025
1.24
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
5 May 2025
0.97
Cons. EPS
1.11
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
18 Feb 2025
1.16
Cons. EPS
1.26
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
4 Nov 2024
0.98
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
6 Aug 2024
0.76
Cons. EPS
0.91
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
7 May 2024
0.7
Cons. EPS
0.79
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
19 Feb 2024
0.83
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
6 Nov 2023
0.71
Cons. EPS
0.75
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
7 Nov 2016
-
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
9 Aug 2016
-
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
9 May 2016
-
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
29 Feb 2016
-
Cons. EPS
0.03
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
9 Nov 2015
-
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
10 Aug 2015
-
Cons. EPS
0.02
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
11 May 2015
-
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
2 Mar 2015
-
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
10 Nov 2014
-
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
11 Aug 2014
-
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
12 May 2014
-
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
27 Feb 2014
-
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
8 Nov 2013
-
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
7 Aug 2013
-
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
8 May 2013
-
Cons. EPS
-
EPS
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
25 Feb 2013
-
Cons. EPS
-
EPS

HALO Earnings Reports FAQ

What is the earnings per share (EPS) for HALO?

The current EPS is 2.74.

What is the company's earnings growth rate?

Over the past 12 years, the earnings growth rate has been approximately 56.12%, reflecting the HALO's performance and NASDAQ (NGS) market conditions.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-17, based on the HALO's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings were 1.72 per share, reported on 2025-10-28. For dividend history, visit the HALO Dividends page.

What is the price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio is 36.82, calculated based on the most recent stock price of $63.33.